Organon Balance Sheet Health
Financial Health criteria checks 1/6
Organon has a total shareholder equity of $493.0M and total debt of $8.7B, which brings its debt-to-equity ratio to 1774.6%. Its total assets and total liabilities are $12.8B and $12.3B respectively. Organon's EBIT is $1.5B making its interest coverage ratio 2.9. It has cash and short-term investments of $763.0M.
Key information
1,774.6%
Debt to equity ratio
US$8.75b
Debt
| Interest coverage ratio | 2.9x |
| Cash | US$763.00m |
| Equity | US$493.00m |
| Total liabilities | US$12.26b |
| Total assets | US$12.75b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 7XP's short term assets ($4.8B) exceed its short term liabilities ($2.8B).
Long Term Liabilities: 7XP's short term assets ($4.8B) do not cover its long term liabilities ($9.5B).
Debt to Equity History and Analysis
Debt Level: 7XP's net debt to equity ratio (1619.9%) is considered high.
Reducing Debt: 7XP's debt to equity ratio has increased from 2.6% to 1774.6% over the past 5 years.
Debt Coverage: 7XP's debt is not well covered by operating cash flow (10.8%).
Interest Coverage: 7XP's interest payments on its debt are not well covered by EBIT (2.9x coverage).